Physician profile
Masood Anwar
NPI 1942278064
$1,116.18
in general payments reported to CMS, 2019-2025
11 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $72.35 · 2021: $28.19 · 2022: $93.92 · 2023: $260 · 2024: $121 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $319.96 | 2019-2021 | |
| Abbott Laboratories | $163.57 | 2019-2023 | Amplatzer Amulet, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Medtronic, INC. | $131.96 | 2022-2024 | Micra, Linq II, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $113.79 | 2023-2024 | Watchman |
| Preventice Services, LLC | $98.79 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.07 | 2021-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $63.07 | 2025 | Assure Wcd |
| Amgen INC. | $54.52 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $33.16 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Alk-Abello, INC | $27.00 | 2025 | Neffy |
| Heartflow, INC. | $18.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Masood Anwar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.